Abstract:Evidence suggests that clinical phenomenology incompletely captures biologically meaningful differentiations in psychosis. The Bipolar and Schizophrenia Network for Intermediate Phenotypes (BSNIP) consortium has employed cognitive and neurophysiological measures to identify three biologically distinct Biotypes, agnostic to clinical features. Biotype 1, 2, and 3, have distinctive neurobiological characteristics: Biotype 1 cases have significant neurocognitive impairment, high numbers of clinically affected relatives, and poor psychosocial functioning. Biotype 2 cases have high neural reactivity and more modest but significant cognitive impairment. Biotype 3 cases have nearly normal cognition and neural reactivity and better psychosocial functioning. As brain white matter is altered in psychosis, we aimed to externally validate the Biotype model using free-water imaging - an advanced diffusion imaging technique to compare differences across Biotypes, as well as across clinical categorization. Diffusion tensor imaging (DTI) data from 69 individuals with schizophrenia, 49 with schizoaffective disorder (SAD), 42 with psychotic bipolar disorder, and 51 healthy controls (HC) from the Baltimore and Hartford sites in the B-SNIP consortium were included. Diffusion within each voxel was modeled using two compartments: isotropic free-water compartment, and a tissue compartment. Measures obtained from this model are the free-water compartment fraction (FW), and the tissue-FA fraction (FAt). Using Tract-based spatial statistics, the ENIGMA-DTI protocols were run on FAt and FW maps. The average FAt and FW within 25 bilateral white matter regions of interest was extracted. A MANCOVA model was used to test for differences in FAt and FW between diagnostic groups and Biotype groups, with age and sex as covariates. A significant group effect for diagnosis was observed in the corpus callosum (CC) (p<0.05, partial eta squared=0.1), whereby those diagnosed with SAD showed lower FAt in CC compared to HC. Using Biotype classification, a significant group effect was also observed for the CC, whereby Biotype 1 showed lower FAt than HC and Biotype 3 (p<0.01, partial eta squared=.13). For FW, no significant group differences were observed for diagnosis. However, group differences for Biotype were observed in the CC, whereby Biotypes 1 and 2 showed elevated FW compared to Biotype 3 and HC (p<0.01, partial eta squared = 0.1). While significant diagnosis comparisons were observed between schizoaffective disorder and HC, larger effects were observed when using Biotype classification. Patients in Biotype 1 group not only showed significant FAt reductions in the CC compared to HC, but also compared to Biotype 3. This is expected as Biotype 1 individuals were shown to be most impaired with regards to the biomarker dimensions of cognitive control and sensorimotor reactivity, whereas Biotype 3 were more comparable to healthy controls. Finally, no differences were observed for FW when grouping by diagnosis, however, when grouping by Biotype, significant elevations were observed for Biotypes 1 and 2. Aligned with our previous studies, FW appears to be a marker of acute response to psychosis, where elevations in FW are observed in individuals who were actively psychotic during scanning. Since neuroinflammation is expected to alter the extracellular FW fraction, it’s possible that neuroinflammatory processes are apparent in these Biotype groups. However, further validation is required. In conclusion, grouping psychosis patients by Biotype may be a more biologically parsimonious approach for parsing heterogeneity of the disorder.

Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers

Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium.

Differentiating Biomarker Features and Familial Characteristics of B-SNIP Psychosis Biotypes

M61. Data-Driven Approach Identified Functionally and Physiologically Distinct Psychosis Subtypes

Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis Biotypes.

850. Identification of Biotypes in Psychosis Using Biomarkers and Ipscs

Neuroanatomical Heterogeneity and Homogeneity in Individuals at Clinical High Risk for Psychosis

Supervised Machine Learning Classification of Psychosis Biotypes Based on Brain Structure: Findings from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP).

9.3 PSYCHOSIS BIOTYPES VERSUS CLINICAL SYNDROMES THROUGH THE PRISM OF INTRINSIC NEURAL ACTIVITY

Neurobiology-based Cognitive Biotypes Using Multi-scale Intrinsic Connectivity Networks in Psychotic Disorders

145. Diagnosis and Biotype Comparisons Across the Psychosis Spectrum: Investigating Amygdala-Hippocampal Differences from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study

Examining Functional Resting-State Connectivity in Psychosis and Its Subgroups in the Bipolar-Schizophrenia Network on Intermediate Phenotypes Cohort

A Diagnosis and Biotype Comparison Across the Psychosis Spectrum: Investigating Volume and Shape Amygdala-Hippocampal Differences from the B-SNIP Study.

Longitudinal Stability of Psychosis Biomarkers: Findings from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP)

SU65. Neural Adaptation Differences among Psychosis Biotypes

O11.4. DIAGNOSIS AND BIOTYPE COMPARISON ACROSS THE PSYCHOSIS SPECTRUM: INVESTIGATING WHITE MATTER MICROSTRUCTURAL DIFFERENCES FROM THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (B-SNIP) STUDY USING FREE-WATER IMAGING

Intrinsic Neural Activity Differences in Psychosis Biotypes: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Consortium

White Matter Microstructure Across Brain-Based Biotypes for Psychosis - Findings from the Bipolar-Schizophrenia Network for Intermediate Phenotypes.

Psychosis Subgroups Differ in Intrinsic Neural Activity but Not Task-Specific Processing.

Genetic Analysis of Psychosis Biotypes: Shared Ancestry-Adjusted Polygenic Risk and Unique Genomic Associations

Intrinsic Neural Activity Differences among Psychotic Illnesses